TRIM33 and myositis disease: Of note, two dysregulated miRNAs characterized in the plasma exosomes of cancer-associated myositis (hsa-let-7f-5p and hsa-miR-143-3p) were also among the predicted interactors of TRIM33 mRNA according to this analysis.